Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Ratings reports.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s stock price hit a new 52-week low on Monday . The stock traded as low as $7.05 and last traded at $7.16, with a volume of 1018130 shares ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

In a recent study, researchers from Japan identified that kaempferol, a flavonoid, produces an anti-inflammatory effect ...

Sgt. Cory Beckman, a five-year veteran of the Jamestown Police Department, shot Devin Quinn Fontenot, 27, Jamestown, after he ...

Nelson Aguilar is an LA-based tech how-to writer and graduate of UCLA. With more than a decade of experience, he covers Apple and Google and writes on iPhone and Android features, privacy and ...

CD4 T helper cells are a type of white blood cell called a lymphocyte that serves an important role in your immune system. These cells help defend the body against infection by directing other "killer ...

To discover how brain cells respond to microgravity, scientists sent tiny clumps of stem-cell derived brain cells called 'organoids' to the International Space Station. Microgravity is known to ...

In the intestines, specialized dendritic cells (DCs) produce an enzyme called ... the researchers induced allergies in mice using the OVA (ovalbumin) protein found in egg whites.

Here we describe FB5P-seq-mAbs, a method that bridges plate-based 5’-end scRNA-seq (FB5P-seq) with recombinant monoclonal antibody cloning and production (Figure 1), and illustrate its use for ...